myeloid/lymphoid neoplasms
Pemazyre Gains New Indication for Myeloid/Lymphoid Neoplasms
The FDA granted a new indication for Pemazyre to treat adults with relapsed or refractory myeloid/lymphoid ...
AUGUST 30, 2022

Load more